Understanding the Link Between the Placenta and Future Cardiovascular Disease

Trends in Cardiovascular Medicine

Volumn 21, Issue 7, 2011, Pages 188-193

  Siddiqui, Nausheen ^a   Hladunewich, Michelle ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; INTRAUTERINE GROWTH RETARDATION; PLACENTA DEVELOPMENT; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; SOLUTIO PLACENTAE; STILLBIRTH;

CARDIOVASCULAR DISEASES; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFARCTION; MALE; PLACENTA; PLACENTA ACCRETA; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; STILLBIRTH; UNITED STATES;

EID: 84864563117     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.05.008     Document Type: Review

References (51)

1. AbdAlla S., Lother H., El Massiery A., Quitterer U. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 2001, 7:1003-1009.
2. Agatisa P.K., Ness R.B., Roberts J.M., et al. Impairment of endothelial function in women with a history of preeclampsia: An indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol 2004, 286:H1389-H1393.
3. Alexander B.T., Llinas M.T., Kruckeberg W.C., Granger J.P. l-Arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure. Hypertension 2004, 43:832-836.
4. Bellamy L., Casas J.P., Hingorani A.D., Williams D.J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis. BMJ 2007, 335:974.
5. Bourghardt J., Bergström G., Krettek A., et al. The endogenous estradiol metabolite 2-methoxyestradiol reduces atherosclerotic lesion formation in female apolipoprotein E-deficient mice. Endocrinology 2007, 148:4128-4132.
6. Brodszki J., Länne T., Laurini R., et al. Vascular mechanical properties and endothelial function in pre-eclampsia with special reference to bilateral uterine artery notch. Acta Obstet Gynecol Scand 2008, 87:154-162.
7. Brown C.E., Gant N.F., Cox K., et al. Low-dose aspirin: II. Relationship of angiotensin II pressor responses, circulating eicosanoids, and pregnancy outcome. Am J Obstet Gynecol 1990, 163:1853-1861.
8. Chambers J.C., Fusi L., Malik I.S., et al. Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001, 285:1607-1612.
9. Crispi F., Domínguez C., Llurba E., et al. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 2006, 195:201-207.
10. Germain A.M., Romanik M.C., Guerra I., et al. Endothelial dysfunction: A link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?. Hypertension 2007, 49:90-95.
11. Gómez O., Figueras F., Martínez J.M., et al. Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome. Ultrasound Obstet Gynecol 2006, 28:802-808.
12. Hamad R.R., Eriksson M.J., Silveira A., et al. Decreased flow-mediated dilation is present 1 year after a pre-eclamptic pregnancy. J Hypertens 2007, 25:2301-2307.
13. Hastie C.E., Smith G.C., Mackay D.F., Pell J.P. Maternal risk of ischaemic heart disease following elective and spontaneous pre-term delivery: Retrospective cohort study of 750 350 singleton pregnancies. Int J Epidemiol 2011, 40:914-919.
14. Haukkamaa L., Salminen M., Laivuori H., et al. Risk for subsequent coronary artery disease after preeclampsia. Am J Cardiol 2004, 93:805-808.
15. Herse F., Dechend R., Harsem N.K., et al. Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension 2007, 49:604-611.
16. Hladunewich M.A., Kingdom J., Odutayo A., et al. Postpartum assessment of the renin angiotensin system in women with previous severe, early-onset preeclampsia. J Clin Endocrinol Metab 2011, 96:3517-3524.
17. Hubel C.A., Wallukat G., Wolf M., et al. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension 2007, 49:612-617.
18. Irgens H.U., Reisaeter L., Irgens L.M., Lie R.T. Long term mortality of mothers and fathers after pre-eclampsia: Population based cohort study. BMJ 2001, 323:1213-1217.
19. + cells as indicators of preeclampsia. Hypertension 2012, 59:861-868.
20. Johansson A., Curran J.E., Johnson M.P., et al. Identification of ACOX2 as a shared genetic risk factor for preeclampsia and cardiovascular disease. Eur J Hum Genet 2011, 19:796-800.
21. Kanasaki K., Palmsten K., Sugimoto H., et al. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 2008, 453:1117-1121.
22. Levine R.J., Lam C., Qian C., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006, 355:992-1005.
23. Lim K.H., Zhou Y., Janatpour M., et al. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol 1997, 151:1809-1818.
24. + progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia. Reprod Sci 2010, 17:643-652.
25. Magness R.R., Cox K., Rosenfeld C.R., Gant N.F. Angiotensin II metabolic clearance rate and pressor responses in nonpregnant and pregnant women. Am J Obstet Gynecol 1994, 171:668-679.
26. Maynard S.E., Min J.Y., Merchan J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658.
27. McDonald S.D., Malinowski A., Zhou Q., et al. Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analyses. Am Heart J 2008, 156:918-930.
28. Merrill D.C., Karoly M., Chen K., et al. Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 2002, 18:239-245.
29. Mongraw-Chaffin M.L., Cirillo P.M., Cohn B.A. Preeclampsia and cardiovascular disease death: Prospective evidence from the child health and development studies cohort. Hypertension 2010, 56:166-171.
30. Morgan T., Craven C., Nelson L., et al. Angiotensinogen T235 expression is elevated in decidual spiral arteries. J Clin Invest 1997, 100:1406-1415.
31. Mosca L., Benjamin E.J., Berra K., et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: A guideline from the American Heart Association. J Am Coll Cardiol 2011, 57:1404-1423.
32. Oney T., Kaulhausen H. The value of the angiotensin sensitivity test in the early diagnosis of hypertensive disorders in pregnancy. Am J Obstet Gynecol 1982, 142:17-20.
33. Ramsay J.E., Stewart F., Greer I.A., Sattar N. Microvascular dysfunction: A link between pre-eclampsia and maternal coronary heart disease. Br J Obstet Gynaecol 2003, 110:1029-1031.
34. Ray J.G., Vermeulen M.J., Schull M.J., Redelmeier D.A. Cardiovascular health after maternal placental syndromes (CHAMPS): Population-based retrospective cohort study. Lancet 2005, 366:1797-1803.
35. Romundstad P.R., Magnussen E.B., Smith G.D., Vatten L.J. Hypertension in pregnancy and later cardiovascular risk: Common antecedents?. Circulation 2010, 122:579-584.
36. Roten L.T., Fenstad M.H., Forsmo S., et al. A low COMT activity haplotype is associated with recurrent preeclampsia in a Norwegian population cohort (HUNT2). Mol Hum Reprod 2011, 17:439-446.
37. Saxena A.R., Karumanchi S.A., Brown N.J., et al. Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy. Hypertension 2010, 55:1239-1245.
38. Smith G.N., Walker M.C., Liu A., et al. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2009, 200:58.e1-58.e8.
39. Sugawara J., Mitsui-Saito M., Hayashi C., et al. Decrease and senescence of endothelial progenitor cells in patients with preeclampsia. J Clin Endocrinol Metab 2005, 90:5329-5332.
40. Valdés G., Germain A.M., Corthorn J., et al. Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation. Endocrine 2001, 16:117-122.
41. Valensise H., Vasapollo B., Gagliardi G., Novelli G.P. Early and late preeclampsia: Two different maternal hemodynamic states in the latent phase of the disease. Hypertension 2008, 52:873-880.
42. Venkatesha S., Toporsian M., Lam C., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006, 12:642-649.
43. Vikse B.E., Hallan S., Bostad L., et al. Previous preeclampsia and risk for progression of biopsy-verified kidney disease to end-stage renal disease. Nephrol Dial Transplant 2010, 25:3289-3296.
44. Voutilainen S., Tuomainen T.P., Korhonen M., et al. Functional COMT Val158Met polymorphism, risk of acute coronary events and serum homocysteine: The Kuopio Ischaemic Heart Disease Risk Factor Study. PLoS ONE 2007, 2:e181.
45. Wallukat G., Homuth V., Fischer T., et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999, 103:945-952.
46. Wilson B.J., Watson M.S., Prescott G.J., et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: Results from cohort study. BMJ 2003, 326:845.
47. Xia Y., Wen H., Bobst S., et al. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J Soc Gynecol Investig 2003, 10:82-93.
48. Yinon Y., Kingdom J.C., Odutayo A., et al. Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: Insights into future vascular risk. Circulation 2010, 122:1846-1853.
49. Zhou C.C., Ahmad S., Mi T., et al. Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension 2008, 51:1010-1019.
50. Zhou C.C., Zhang Y., Irani R.A., et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med 2008, 14:855-862.
51. Zhou Y., Damsky C.H., Fisher S.J. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype: One cause of defective endovascular invasion in this syndrome?. J Clin Invest 1997, 99:2152-2164.